Terms: = Germ cell tumor AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Diagnosis
31 results:
1. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
[TBL] [Abstract] [Full Text] [Related]
2. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
3. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract] [Full Text] [Related]
4. Brain and Spinal Cord tumors of Embryonic Origin.
Lampros M; Alexiou GA
Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
[TBL] [Abstract] [Full Text] [Related]
6. germline pathogenic
Witkowski L; Nichols KE; Jongmans M; van Engelen N; de Krijger RR; Herrera-Mullar J; Tytgat L; Bahrami A; Mar Fan H; Davidson AL; Robertson T; Anderson M; Hasselblatt M; Plon SE; Foulkes WD
J Med Genet; 2023 Oct; 60(10):987-992. PubMed ID: 36813544
[TBL] [Abstract] [Full Text] [Related]
7. Fine needle aspiration cytology of metastatic smarca4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract] [Full Text] [Related]
8. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
9. Primary cutaneous smarca4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and molecular comparison to eight visceral counterparts.
Russell-Goldman E; MacConaill L; Hanna J
Mod Pathol; 2022 Dec; 35(12):1821-1828. PubMed ID: 36085356
[TBL] [Abstract] [Full Text] [Related]
10. Case report of bilateral ovarian fibromas associated with de novo germline variants in PTCH1 and smarca4.
Higashimoto T; Smith CH; Hopkins MR; Gross J; Xing D; Lee JW; Morris T; Bodurtha J
Mol Genet Genomic Med; 2022 Sep; 10(9):e2005. PubMed ID: 35775118
[TBL] [Abstract] [Full Text] [Related]
11. The Impact of Surgical Resection and Adjuvant Therapy on Survival in Pediatric Patients with Atypical Teratoid/Rhabdoid tumor: Systematic Review and Pooled Survival Analysis.
Egiz A; Kannan S; Asl SF
World Neurosurg; 2022 Aug; 164():216-227. PubMed ID: 35470083
[TBL] [Abstract] [Full Text] [Related]
12. Thorahcic smarca4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract] [Full Text] [Related]
13. Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol; 2022 Jan; 35(Suppl 1):36-50. PubMed ID: 34663914
[TBL] [Abstract] [Full Text] [Related]
14. Paediatric atypical teratoid/rhabdoid tumour of the pineal region mimicking a meningioma: a case report and literature review.
Tan X; Xiao M; Jiang W; Yue C; Qu L; Zhao G
Br J Neurosurg; 2023 Dec; 37(6):1749-1752. PubMed ID: 33726577
[TBL] [Abstract] [Full Text] [Related]
15. Atypical teratoid/rhabdoid tumors (ATRTs) with smarca4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract] [Full Text] [Related]
16. Cytology of smarca4-Deficient Thoracic Neoplasms: Comparative Analysis of smarca4-Deficient Non-Small cell Lung Carcinomas and smarca4-Deficient Thoracic Sarcomas.
Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent Loss of smarca4 in Sinonasal Teratocarcinosarcoma.
Rooper LM; Uddin N; Gagan J; Brosens LAA; Magliocca KR; Edgar MA; Thompson LDR; Agaimy A; Bishop JA
Am J Surg Pathol; 2020 Oct; 44(10):1331-1339. PubMed ID: 32520761
[TBL] [Abstract] [Full Text] [Related]
18. germline mutations of smarca4 in small cell carcinoma of the ovary, hypercalcemic type and in smarca4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
[TBL] [Abstract] [Full Text] [Related]
19. MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.
Meel MH; Guillén Navarro M; de Gooijer MC; Metselaar DS; Waranecki P; Breur M; Lagerweij T; Wedekind LE; Koster J; van de Wetering MD; Schouten-van Meeteren N; Aronica E; van Tellingen O; Bugiani M; Phoenix TN; Kaspers GJL; Hulleman E
Neuro Oncol; 2020 Jan; 22(1):58-69. PubMed ID: 31504799
[TBL] [Abstract] [Full Text] [Related]
20. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
[Next]
